Back
Summit Therapeutics Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
30
SMMT
Summit Therapeutics
Last Price:
$19.53
Seasonality Move:
21.32%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.26 | Sell |
| 20-day SMA: | 23.83 | Sell |
| 50-day SMA: | 23.31 | Sell |
| 200-day SMA: | 20.26 | Buy |
| 8-day EMA: | 22.1 | Sell |
| 20-day EMA: | 23.45 | Sell |
| 50-day EMA: | 23.22 | Sell |
| 200-day EMA: | 19.21 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.76 | Sell |
| Relative Strength Index (14 RSI): | 42.54 | Sell |
| Chaikin Money Flow: | 11851779 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.83 - 26.57) | Sell |
| Bollinger Bands (100): | (18.37 - 25.13) | Sell |
Summit Therapeutics Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 20.62 while SMMT 8-day simple moving average is 23.26, which is a Sell signal.
-
The stock price of SMMT is 20.62 while Summit Therapeutics 20-day SMA is 23.83, which makes it a Sell.
-
Summit Therapeutics 50-day simple moving average is 23.31 while SMMT share price is 20.62, making it a Sell technically.
-
SMMT stock price is 20.62 and Summit Therapeutics 200-day simple moving average is 20.26, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
30
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a SellThe current Summit Therapeutics [SMMT] share price is $20.62. The Score for SMMT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics Stock Info
Market Cap:
15.3B
Price in USD:
20.62
Share Volume:
12.2M
Summit Therapeutics 52-Week Range
52-Week High:
36.91
52-Week Low:
6.78
Sell
30
Summit Therapeutics (SMMT)
is a Sell
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 20.62 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 20.62 while SMMT 8-day exponential moving average is 22.10, which is a Sell signal.
-
The stock price of SMMT is 20.62 while Summit Therapeutics 20-day EMA is 23.45, which makes it a Sell.
-
Summit Therapeutics 50-day exponential moving average is 23.22 while SMMT share price is 20.62, making it a Sell technically.
-
SMMT stock price is 20.62 and Summit Therapeutics 200-day simple moving average is 19.21, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is -0.76, suggesting Summit Therapeutics is a Sell
-
Summit Therapeutics Relative Strength Index (RSI) is 42.54, which suggest Summit Therapeutics is oversold
-
The Bollinger Bands (25) for Summit Therapeutics is (21.83 - 26.57), which suggest Summit Therapeutics is a Sell
-
The Bollinger Bands (100) for Summit Therapeutics is (18.37 - 25.13), which suggest Summit Therapeutics is a Sell
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.